X

NetworkNewsBreaks – NurExone Biologic Inc. (TSX.V NRX) (OTCQB: NRXBF) to Highlight Exosome Technology, Pipeline and US Initiatives at NY Conference

Disseminated on behalf of NurExone Biologic Inc. (TSX.V NRX) (OTCQB:NRXBF) and may include paid advertising.

NurExone Biologic (TSX.V NRX) (OTCQB:NRXBF) will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference taking place Sept. 9-10 in New York City. Yoram Drucker, the company’s co-founder and chairman, is scheduled to present to investors and conduct one-on-one meetings. NurExone plans to use the event to showcase its exosome-based therapeutic platform, development pipeline, and U.S. manufacturing and commercialization initiatives as it advances preclinical programs and prepares for potential clinical development.

To view the full press release, visit https://nnw.fm/mZbWx

About NurExone Biologic Inc.

NurExone Biologic is a biotechnology company focused on developing regenerative exosome-based therapies for central nervous system injuries. Its lead candidate, ExoPTEN, has shown strong preclinical potential in treating acute spinal cord and optic nerve damage, and the company also aims to supply quality exosomes and minimally invasive targeted delivery systems while anchoring its North American strategy through its Exo-Top platform.

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer

NetworkNewsWire
Austin, Texas
www.NetworkNewsWire.com
512.354.7000 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is powered by IBN

Chris@NNW:
Related Post